Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 5/20 | 0.55 |
| ▸ | NOS1 | P29475 | 4/20 | 0.55 |
| ▸ | NOS3 | P29474 | 3/20 | 0.55 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.39 |
| ▸ | ESR1 | P03372 | 6/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | SLC10A2 | Q12908 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8329711 | 0.87 | NOS2 (0.41) | NOS2NOS1NOS3 | |
| SCHEMBL8326231 | 0.87 | NOS2 (0.41) | NOS2NOS1NOS3 | |
| SCHEMBL8326237 | 0.87 | NOS2 (0.41) | NOS2NOS1NOS3 | |
| SCHEMBL6766749 | 0.85 | NOS2 (0.39) | NOS2NOS1NOS3 | |
| SCHEMBL8329440 | 0.84 | NOS2 (0.53) | NOS2NOS1NOS3ESR1 | |
| SCHEMBL8328239 | 0.82 | NOS1 (0.37) | NOS2NOS1NOS3ESR1 | |
| SCHEMBL8328137 | 0.82 | NOS2 (0.51) | NOS2NOS1NOS3 | |
| SCHEMBL2834751 | 0.81 | NOS1 (0.44) | NOS2NOS1NOS3 | |
| SCHEMBL5672155 | 0.81 | NOS2 (0.36) | NOS2NOS1NOS3 | |
| SCHEMBL8329772 | 0.81 | NOS2 (0.39) | NOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5972975-A | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase | MERCK & CO., INC. (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1996018616-A1 | SUBSTITUTED 2-AMINOPYRIDINES AS INHIBITORS OF NITRIC OXIDE SYNTHASE | MERCK & CO., INC. (US) | 1996-06-20 | — | — | WO | disclosed |